# Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer

> **NCT00372476** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 33 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Imatinib and Vinorelbine

## Key facts

- **NCT ID:** NCT00372476
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00372476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00372476, "Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00372476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*